logo

For the Inventor, By the Inventor

Hino, Japan

Yorimasa Suwa

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Teijin Limited, Reverse Proteomics Research Institute, Osaka Bioscience Institute. Active years: 1989-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yorimasa Suwa. Retrieved from https://idiyas.com/inventor/yorimasa-suwa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 50.0

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Tokyo, JP (1989 - 2006)
  • Chiba, JP (2010)
  • Hino, JP (2005 - 2012)

Company Filing History:

goldMedal6 out of 1,605 
 
Teijin Limited
 patents
silverMedal4 out of 13 
 
Reverse Proteomics Research Institute
 patents
bronzeMedal1 out of 19 
 
Osaka Bioscience Institute
 patents
where one patent can have more than one assignee

Years Active: 1989-2012

Loading Chart...
10 patents (USPTO):Explore Patents
1. 8178077 - Drug development target protein and target gene, and method of screening (2012-05-15),
2. 8153385 - Target protein and target gene in drug designing and screening method (2012-04-10),
3. 8058009 - Target protein and target gene in drug designing and screening method (2011-11-15),
4. 7754497 - Method for immobilizing proteins (2010-07-13),
5. 7071359 - Neuropathy improvers containing nitrogenous compounds as the active ingredient (2006-07-04),
6. 6884819 - Neuropathy remedies (2005-04-26),
7. 5374713 - Peptide inhibitors of phospholipase A.sub.2 purified from inflammatory (1994-12-20),
8. 5344764 - Protein inhibitors of phospholipase A.sub.2 purified from inflammatory (1994-09-06),
9. 5116942 - Protein having an inflammatory phospholipase A.sub.2 inhibitory activity (1992-05-26),
10. 4810780 - Protein having phospholipase A2 inhibitory activity (1989-03-07),

Title: Yorimasa Suwa: Innovator in Drug Development

Introduction

Yorimasa Suwa is a prominent inventor based in Hino, Japan. He has made significant contributions to the field of drug development, holding a total of 10 patents. His work focuses on identifying target proteins and genes that can lead to the discovery of novel pharmaceuticals.

Latest Patents

Suwa's latest patents include innovative methods for drug development targeting specific proteins and genes. One of his notable inventions provides novel target proteins and target genes for drug discovery, enabling the development of new drugs. This includes NCS proteins and genes, screening methods for drugs aimed at treating central nervous diseases, and methods for producing drug derivatives. Another patent focuses on a target protein and gene for drug discovery, particularly in developing antiallergic drugs and regulators for allergic diseases.

Career Highlights

Throughout his career, Yorimasa Suwa has worked with reputable organizations such as Teijin Limited and Reverse Proteomics Research Institute Co., Ltd. His experience in these companies has allowed him to advance his research and contribute to significant innovations in drug development.

Collaborations

Suwa has collaborated with notable colleagues, including Atsushi Imaizumi and Masahiro Okada. These partnerships have further enhanced his research capabilities and led to impactful advancements in the field.

Conclusion

Yorimasa Suwa is a distinguished inventor whose work in drug development has the potential to revolutionize the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…